Your session is about to expire
← Back to Search
Non-nutritive Sweetener
Non-nutritive Sweeteners for Metabolic Syndrome
N/A
Waitlist Available
Led By Marie-Claude Vohl
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Regular use of medication affecting study parameters
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will test the effects of two types of non-nutritive sweeteners, stevia and aspartame, on metabolic health and the gut microbiome.
Who is the study for?
This trial is for men and women who are generally healthy and regularly consume soft drinks, ranging from 4 cans a week up to 4 cans a day. It's not suitable for those with recent surgeries, allergies to drink ingredients, recent antibiotic use, heavy alcohol consumption, or changes in medication or weight.
What is being tested?
The study tests the effects of daily consumption of three types of beverages over 10 weeks: regular sugary soft drinks, diet soft drinks with artificial sweeteners like aspartame, and stevia-sweetened soft drinks on metabolic health and gut microbiome.
What are the potential side effects?
Potential side effects may include changes in metabolism or gut health due to the different sweeteners used. These could affect blood sugar levels, digestion processes or cause other metabolic disturbances.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I regularly take medication that could affect the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Stevia beveragesExperimental Treatment1 Intervention
Soft drinks sweetened with natural non-nutritive sweeteners (i.e. steviol glycosides)
Group II: Diet beveragesExperimental Treatment1 Intervention
Soft drinks sweetened with artificial non-nutritive sweeteners (i.e. aspartame, acesulfame-K)
Group III: Regular beveragesActive Control1 Intervention
Sugar sweetened soft drinks
Find a Location
Who is running the clinical trial?
Laval UniversityLead Sponsor
434 Previous Clinical Trials
178,500 Total Patients Enrolled
26 Trials studying Metabolic Syndrome
1,974 Patients Enrolled for Metabolic Syndrome
Marie-Claude VohlPrincipal InvestigatorLaval University
3 Previous Clinical Trials
141 Total Patients Enrolled
2 Trials studying Metabolic Syndrome
118 Patients Enrolled for Metabolic Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had surgery in the last 3 months and do not plan to during the study.You are allergic or intolerant to any ingredients in soft drinks.I have a condition like high blood pressure, diabetes, or high cholesterol.I have not taken antibiotics in the last 3 months.I have not changed my use of natural health products in the last 3 months.Your weight has changed by more than 5% in the last 3 months.People who drink between 4 cans of soft drinks per week to 4 cans per day.I am in good health.You drink more than 2 alcoholic drinks per day.I regularly take medication that could affect the study.My medication type or dose has not changed in the past year.You drink more than 4 cans of soda every day.
Research Study Groups:
This trial has the following groups:- Group 1: Regular beverages
- Group 2: Diet beverages
- Group 3: Stevia beverages
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.